1 / 13

MVRBC SOP Changes

MVRBC SOP Changes. That will affect Client Hospitals October, 2011 TAC Meeting. Effective DATE . Monday, September 19 th. Antibody Screens. All antibody ID samples will receive a Room Temperature 30 minute antibody screen

chavi
Télécharger la présentation

MVRBC SOP Changes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MVRBC SOP Changes That will affect Client Hospitals October, 2011 TAC Meeting

  2. Effective DATE Monday, September 19th

  3. Antibody Screens • All antibody ID samples will receive a Room Temperature 30 minute antibody screen • Performed to catch any cold reactive antibodies including autoantibodies • All antibody ID samples will receive a screen with PeG or LISS in addition to the RT screen. • Allows us to view another perspective on antibody reactivity. • Not all antibodies will react with every method.

  4. Antibody Identification • Techs will be testing FULL 10-11 cell panels on patients with previously identified antibodies. • Prior practice was to choose selected cells to rule in antibody with one cell and choose cells to rule out other clinically significant antibodies. • Will allow MVRBC to better provide for client hospitals by testing with complete panels. • Minimizes chances that an antibody will be missed, such as an antibody to a low frequency antigen.

  5. DAT / Elution Testing • All Antibody ID Samples will receive a DAT • MVRBC wants to meet our patient’s need by providing the most complete workup • All positive DAT / AHG positive autocontrols will have an eluate performed regardless of the transfusion history • Prior practice was to perform an eluate if the patient has been transfused within the last three months. • Can be a safety issue – How accurate is the transfusion history we receive? Have they been treated at another hospital we don’t know about?

  6. Absorption on Eluates • Eluates will only be adsorbed if the patient has been transfused within 21 days • Prior process was to absorb if the patient had been transfused within 3 months. • TM 16th ed. States that an antibody will typically be produced by 14-21 days after transfusion at which point it will be detected in plasma.

  7. Antibody Titers • Will see Antibody Score reported with titer results. • Weak reactivity often extends beyond a 1+ which is the cut off for reporting antibody titers. • The score is calculated based on strength of reactivity of each tube. • The score can increase without the antibody titer increasing – Indicating antib0dy production or possible clinical significance • Dr. Marshall has written a letter describing the additional information being reported with antibody titers. • A copy of the letter will be available from Ronelle.

  8. Critical Values • MVRBC staff will begin reporting and documenting who they spoke with for values that are considered critical values to MVRBC. • Each hospital is recommended to follow your own policy / procedures. • Some of the more common critical values include the following: • Positive DAT • Critical Antib0dy Titer (≥ 16, increase of 2 dilutions or a score of 10 points) • Percent compatibility of < 10% based on patient’s antibodies

  9. Antigen Testing on Tail Segments • A new form will be faxed if you send tail segments from your inventory for antigen testing • This form (Z-132) provides verification for the hospitals that the testing was performed • Considered similar to the antigen typing tag attached to units issued to your facility

  10. Double Red Blood Cells • Antigen typing on double red cells will now be typed individually and charged for testing performed. • Prior practice was to antigen type one unit and label both parts of the unit as antigen negative • Resulted in ONE antigen type fee • As a safety concern, the new practice will require BOTH parts to be tested and labeled as test results indicated • Resulting in an antigen testing fee for each unit ordered

  11. Effective DATE Monday, November 7th

  12. Final Consult Reports • Beginning Monday, November 7thfinal consult reports will not be faxed to each hospital. • The report will be placed in an envelope and sent with PMD courier to appropriate hospital • Refining process to meet our clients needs • We recognize the extra work that is involved each time a report is issued

  13. Questions / Comments?

More Related